Delivery Order SPE2DB20D7059-SPE2DB25FQAU2

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $60,618.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, and has an ultimate completion date of August 26, 2024. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award for $5,574.98 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to provide 4564767693 ! IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, with a period of performance through June 3, 2024. The contract is a Firm Fixed Price award with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,747.95 Firm Fixed Price Delivery Order is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML medical products. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,791.32 delivery order is for IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a prescription medication. This order is a firm fixed-price contract with a completion date of November 30, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $4,693.78 firm fixed price delivery order is for the provision of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML to support Department of Defense (DoD) healthcare programs. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,107.22 firm fixed-price delivery order is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, with a performance period through November 14, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.19 delivery order is for IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has a firm fixed price and is set to expire on July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,904.92, is for the delivery of 4566894312 IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML to support military and federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 13, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award, valued at $16,399.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a medication, with an ultimate completion date of September 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, identified as SPE2DB20D2104|SPE2DB24FV67Y, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,151.53, is a delivery order for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of August 13, 2024. This award is likely part of a larger Indefinite Delivery...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQAU2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,213.12 firm fixed-price delivery order covers the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, to support military healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the U.S. military globally. This IDC, which runs through November 2026, encompasses critical medical commodities across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition.

Generated 5/27/25, 9:54 AM